Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sheel BiotechNSE:SHEEL 18 Interest Coverage is 7.95 as of Mar. 2026, which is at its 10-year median of 7.95. GuruFocus rates NSE:SHEEL with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 1,514 Consumer Packaged Goods companies, Sheel Biotech ranks worse than 51.92% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Sheel Biotech's
Operating Income
for the
six
months ended in Mar. 2026 was ₹152 Mil. Sheel Biotech's Interest Expense for the
six
months ended in Mar. 2026 was ₹-19 Mil.
Sheel Biotech's interest coverage for the quarter that ended in Mar. 2026 was 7.95.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Sheel Biotech's Interest Coverage or its related term are showing as below:
NSE:SHEEL'
s Interest Coverage Range Over the Past 10 Years
Min: 5.99 Med: 7.95 Max: 10.46
Current: 7.95
NSE:SHEEL's Interest Coverage is ranked worse than 51.92% of 1514
companies
in the Consumer Packaged Goods industry
Industry Median: 8.605
vs NSE:SHEEL: 7.95
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Sheel Biotech Interest Coverage Related Terms
Sheel Biotech Interest Coverage Historical Data
* Premium members only.
The historical data trend for Sheel Biotech's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Sheel Biotech Interest Coverage Chart
Sheel Biotech Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Mar26
Interest Coverage
5.99
6.94
10.46
7.97
7.95
Sheel Biotech Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
Mar26
Interest Coverage
5.99
6.94
10.46
7.97
7.95
NSE:SHEEL vs ADM, BG, TSN: Interest Coverage Comparison
For the Farm Products subindustry, Sheel Biotech's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sheel Biotech Interest Coverage vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Sheel Biotech's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Sheel Biotech's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech (NSE:SHEEL) has a Interest Coverage of 7.95 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sheel Biotech and its competitors. This is near median its historical median of 7.95. Over the past decade, Sheel Biotech's Interest Coverage has ranged from 5.99 to 10.46. According to the industry distribution chart, Sheel Biotech ranks #786 out of 1514 companies in the Consumer Packaged Goods industry, placing it in the top 51.9%.
Is Sheel Biotech's Interest Coverage too high?
Sheel Biotech's current Interest Coverage of 7.95 is near median its 10-year median of 7.95. Over the past 10 years, this metric has ranged from a low of 5.99 to a high of 10.46. The Consumer Packaged Goods industry median Interest Coverage is 8.61. Sheel Biotech's value of 7.95 is 7.6% below this industry median. Based on the distribution chart, Sheel Biotech ranks #786 out of 1514 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Sheel Biotech has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's Interest Coverage compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Sheel Biotech ranks #786 out of 1514 companies for Interest Coverage. This places Sheel Biotech in the lower half of its industry. The industry median Interest Coverage is 8.61. Sheel Biotech's value of 7.95 is 7.6% below this benchmark. Historically, Sheel Biotech's own Interest Coverage has ranged from 5.99 to 10.46 over the past decade. While the company's 10-year median is 7.95 vs. the industry median of 8.61, Sheel Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Consumer Packaged Goods company?
The median Interest Coverage among Consumer Packaged Goods companies is 8.61, based on 1,514 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sheel Biotech's current Interest Coverage of 7.95 is 7.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sheel Biotech and its competitors. For the Consumer Packaged Goods industry, the median Interest Coverage is 8.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sheel Biotech's current Interest Coverage is 7.95, which is near median its own 10-year median of 7.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current Interest Coverage of 7.95. The current Interest Coverage is 7.95, which is near median its 10-year median of 7.95 and 7.6% below the Consumer Packaged Goods industry median of 8.61. Sheel Biotech's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current Interest Coverage is 7.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
18GF Score
Get the complete analysis for NSE:SHEEL
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SHEEL has been successfully added to your 
